Is VTRS Worth Buying in 2026?

Viatris Inc. Common Stock

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-08-23

Here’s whether Viatris Inc. Common Stock (VTRS) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Neutral.

🔵
Neutral

Positives: trading above the 200-day MA (long-term uptrend intact); 50-day MA is rising (+0.35% over 10 days); strong 1-year return of +52.7%. Concerns: below the 50-day MA (medium-term momentum negative); RSI 25 — oversold. Currently 11.3% off its 52-week high. Score: +2/7.

Ready to act on this? 📈 Trade on Webull

VTRS is holding above its long-term 200-day MA ($14.42) but has slipped below the 50-day MA ($16.60), pointing to short-term weakness in an otherwise intact trend. An RSI of 25.4 has dropped into oversold territory, which has historically preceded short-term bounces. The 1-year return of +52.7% compares to +20.5% for SPY (beat the market by 32.2%).

$10,000 invested 1 year ago → $15,267 today
vs. S&P 500 (SPY) — same period beat market by 32.2%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($14.42)
Above 50-day MA ($16.60)
!RSI(14) neutral zone (30–70) — currently 25.4
Positive return (+52.7%)
!Within 10% of period high (−11.3%)
Period Range $16.32
$9.43 $18.39
RSI (14) 25.4
0 · OversoldOverbought · 100

Key Metrics

Price$16.32
Period Return+52.7%
Period High$18.39
Period Low$9.43
Drawdown−11.3%
MA-50$16.60
MA-200$14.42
RSI (14)25.4
Avg Volume (30d)10.0M
vs. SPYbeat by 32.2%
Return Rank#241 of 999

Trade VTRS

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers